Lukic I, Getselter D, Ziv O, Oron O, Reuveni E, Koren O, Elliot E (2019) Antidepressants affect gut

microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like

behavior. Transl Psychiatry 9:133. https://doi.org/10.1038/s41398-019-0466-x

Mabbott NA, Kobayashi A, Sehgal A, Bradford BM, Pattison M, Donaldson DS (2015) Aging and

the mucosal immune system in the intestine. Biogerontology 16(2):133–145

MacQueen GM, Frey BN, Ismail Z, Jaworska N, Síteiner M, Van Lieshout RJ, Kennedy SH, Lam

RW, Milev RV, Parikh SV, Ravindran AV (2016) CANMAT Depression Working Group

(2016): Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical guidelines

for the Management of Adults with major depressive disorder: section 6. Special populations:

youth, women, and the elderly. Can J Psychiatr 61(9):588–603

Madhavan A, LaGorio LA, Crary MA, Dahl WJ, Carnaby GD (2016) Prevalence of and risk factors

for dysphagia in the community dwelling elderly: a systematic review. J Nutr Health Aging

20(8):806–815

Maffei VJ, Kim S, Blanchard E, Luo M, Jazwinski SJ, Taylor CM, Welsh DA (2017) Biological

aging and the human gut microbiota. J Gerontol A Biol Sci Med Sci 72(11):1474–1482

Maijo M, Clements SJ, Ivory K, Nicoletti C, Carding SR (2014) Nutrition, diet and

immunosenescence. Mech Ageing Dev 136–137:116–128

Mangoni AA, Jackson HD (2003) Age-related changes in pharmacokinetics and pharmacodynam-

ics: basic principles and practical applications. Br J Clin Pharmacol 57(1):6–14

Mariat D, Firmesse O, Levenez F, Guimaraes V, Sokol H, Dore J, Corthier G, Furet JP (2009) The

Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9:

123

McLean AJ, Le Couteur DG (2004) Aging biology and geriatric clinical pharmacology. Pharmacol

Rev 56(2):163–184

Mehta DC, Short JL, Hilmer SN, Nicolazzo JA (2015) Drug access to the central nervous system in

Alzheimer's disease: preclinical and clinical insights. Pharm Res 32(3):819–839

Mikocka-Walus A, Prady SL, Pollok J, Esterman AJ, Gordon AL, Knowles S, Andrews JM (2019)

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.

Cochrane Database Syst Rev 2019(4):CD012680. https://doi.org/10.1002/14651858.

CD012680.pub2

Moore AR, O'Keeffe ST (1999) Drug-induced cognitive impairment in the elderly. Drugs Aging

15(1):15–28

Morley JE (2007) The aging gut: physiology. Clin Geriatr Med 23(4):757–767., v-vi. https://doi.

org/10.1016/j.cger.2007.06.002

Moxey ED, O’Conor JP, Novielli KD, Teutsch S, Nash DB (2003) Prescription drug use in the

elderly: a descriptive analysis. Health Care Financ Rev 24(4):127–141

Murad K, Kitzman DW (2012) Frailty and multiple comorbidities in the elderly patient with heart

failure: implications for management. Heart Fail Rev 17:581–588

Nayak BN, Singh RB, Buttar HS (2019) Role of tryptophan in health and disease: systematic review

of the anti-oxidant, anti-inflammation, and nutritional aspects of tryptophan and its metabolites.

World Heart J 11(2):161–178

Nnodim JO (1988) Stereological assessment of age-related changes in lipid droplet surface area and

vascular volume in rat interscapular brown adipose tissue. Anat Rec 220(4):357–363

O’Brian FE, Dinan TG, Griffin BT, Cryan JF (2011) Interactions between antidepressants and

P-glycoprotein at the blood–brain barrier: clinical significance of in vitro and in vivo findings.

Br J Pharmacol 165:289–312

O’Brian FE, O’Connor RM, Clarke G, Dinan TG, Griffin BT, Cryan JF (2013) P-glycoprotein

inhibition increases the brain distribution and antidepressant-like activity of escitalopram in

rodents. Neuropsychopharmacology 38:2209–2219

Oscanoa TJ, Lizaraso F, Carvajal A (2017) Hospital admissions due to adverse drug reactions in the

elderly. A meta-analysis. Eur J Clin Pharmacol 73(6):759–770. https://doi.org/10.1007/s00228-

017-2225-3

15

The Importance of Drug Dose Adjustment in Elderly Patients with Special. . .

269